Recherche
-
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study
(EP-Europace. vol. 22, n° 2, pp. 205-215, 2020)Article de revue -
Benefit-risk of rivaroxaban 20 or 15mg compared to vitamin-K antagonists in patients with non-valvular atrial fibrillation: a cohort study in the French nationwide claims database
(European Heart Journal. vol. 39, pp. 1014-1014, 2018-08)Article de revue -
Medications Recommended for Secondary Prevention After First Acute Coronary Syndrome: Effectiveness of Treatment Combinations in a Real-Life Setting
(Clinical Pharmacology and Therapeutics. vol. 103, n° 6, pp. 1038-1046, 2018-06)Article de revue -
Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample
(Drug Safety. vol. 41, n° 11, pp. 1049-1058, 2018-11)Article de revue -
Patterns of quadruple therapy use including bismuth for Helicobacter pylori eradication: A cohort study in the French national claims database
(Thérapie. vol. 76, n° 5, pp. 435-440, 2021-09)Article de revue -
Comparative Real-Life Effectiveness and Safety of Dabigatran or Rivaroxaban vs. Vitamin K Antagonists: A High-Dimensional Propensity Score Matched New Users Cohort Study in the French National Healthcare Data System SNDS
(Am J Cardiovasc Drugs. vol. 20, n° 1, pp. 81-103, 2020)Article de revue -
Effectiveness of Cetuximab as First-Line Therapy for Patients With Wild-Type KRAS and Unresectable Metastatic Colorectal Cancer in Real-Life Practice: Results of the EREBUS Cohort
(Clinical Colorectal Cancer. vol. 17, n° 2, pp. 129-139, 2018-06)Article de revue -
Pharmacological treatment patterns in heart failure: a population-based cohort study
(Eur J Clin Pharmacol. vol. 76, n° 1, pp. 97-106, 2020)Article de revue -
Previous Drug Exposure in Patients Hospitalised for Acute Liver Injury: A Case-Population Study in the French National Healthcare Data System
(Drug safety. vol. 42, n° 4, pp. 559-572, 2019-04)Article de revue -
Effectiveness and Safety of Standard and Reduced Doses of Dabigatran Compared to Rivaroxaban in Nonvalvular Atrial Fibrillation: Long-Term Results from a Cohort Study in the French Nationwide Claims Database
(Journal of the American College of Cardiology. vol. 75, n° 11, pp. 357, 2020)Article de revue